Paratuberculosis and Crohn's disease

Paratuberculosis: Organism, Disease, Control

Volumn , Issue , 2010, Pages 40-49

  Behr, Marcel A ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80055075863     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (59)

1. Abubakar, I., Myhill, D.J., Hart, A.R., Lake, I.R., Harvey, I., Rhodes, J.M., Robinson, R., Lobo, A.J., Probert, C.S. and Hunter, P.R. (2007) A case-control study of drinking water and dairy products in Crohn's disease-further investigation of the possible role of Mycobacterium avium paratuberculosis. American Journal of Epidemiology 165, 776-783.
2. Abubakar, I., Myhill, D., Aliyu, S.H. and Hunter, P.R. (2008) Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn's disease using nucleic acid-based techniques: a systematic review and metaanalysis. Inflammatory Bowel Disease 14, 401-410.
3. Austin, C.M., Ma, X. and Graviss, E.A. (2008) Common nonsynonymous polymorphisms in the NOD2 gene are associated with resistance or susceptibility to tuberculosis disease in African Americans. Journal of Infectious Diseases 197, 1713-1716.
4. Autschbach, F., Eisold, S., Hinz, U., Zinser, S., Linnebacher, M., Giese, T., Loffler, T., Buchler, M.W. and Schmidt, J. (2005) High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn's disease. Gut 54, 944-949.
5. Behr, M.A. and Hanley, J. (2008) Antimycobacterial therapy for Crohn's disease: a reanalysis. The Lancet Infectious Diseases 8, 344.
6. Behr, M.A. and Kapur, V. (2008) The evidence for Mycobacterium paratuberculosis in Crohn's disease. Current Opinion in Gastroenterology 24, 17-21.
7. Behr, M.A. and Schurr, E. (2006) Mycobacteria in Crohn's disease: a persistent hypothesis. Inflammatory Bowel Disease 12, 1000-1004.
8. Blackmore, T.K., Manning, L., Taylor, W.J. and Wallis, R.S. (2008) Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes. Clinical Infectious Diseases 47, e83-e85.
9. Bull, T.J., Hermon-Taylor, J., Pavlik, I., El Zaatari, F. and Tizard, M. (2000) Characterization of IS900 loci in Mycobacterium avium subsp. paratuberculosis and development of multiplex PCR typing. Microbiology 146, 2185-2197.
10. Bull, T.J., McMinn, E.J., Sidi-Boumedine, K., Skull, A., Durkin, D., Neild, P., Rhodes, G., Pickup, R. and Hermon-Taylor, J. (2003) Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease. Journal of Clinical Microbiology 41, 2915-2923.
11. Cadwell, K., Liu, J.Y., Brown, S.L., Miyoshi, H., Loh, J., Lennerz, J.K., Kishi, C., Kc, W., Carrero, J.A., Hunt, S., Stone, C.D., Brunt, E.M., Xavier, R.J., Sleckman, B.P., Li, E., Mizushima, N., Stappenbeck, T.S. and Virgin, H.W. (2008) A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456, 259-263.
12. Chase-Topping, M., Gally, D., Low, C., Matthews, L. and Woolhouse, M. (2008) Super-shedding and the link between human infection and livestock carriage of Escherichia coli O157. Nature Reviews Microbiology 6, 904-912.
13. Chiodini, R.J. (1989) Crohn's disease and the mycobacterioses: a review and comparison of two disease entities. Clinical Microbiology Reviews 2, 90-117.
14. Cho, J.H. (2008) The genetics and immunopathogenesis of inflammatory bowel disease. Nature Reviews Immunology 8, 458-466.
15. Coulombe, F., Divangahi, M., Veyrier, F., Gleason, J.L., Yang, Y., Kelliher, M.A., Pandey, A.K., Sassetti, C.M., Reed, M.B. and Behr, M.A. (2009) Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide. Journal of Experimental Medicine 206, 1709-1716.
16. Dalziel, T.K. (1913) Chronic interstitial enteritis. British Medical Journal ii, 1068-1070.
17. Divangahi, M., Mostowy, S., Coulombe, F., Kozak, R., Guillot, L., Veyrier, F., Kobayashi, K.S., Flavell, R.A., Gros, P. and Behr, M.A. (2008) NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. Journal of Immunology 181, 7157-7165.
18. Evans, J.T., Smith, E.G., Banerjee, A., Smith, R.M., Dale, J., Innes, J.A., Hunt, D., Tweddell, A., Wood, A., Anderson, C., Hewinson, R.G., Smith, N.H., Hawkey, P.M. and Sonnenberg, P. (2007) Cluster of human tuberculosis caused by Mycobacterium bovis: evidence for person-to-person transmission in the UK. The Lancet 369, 1270-1276.
19. Faber, W.R., Jensema, A.J. and Goldschmidt, W.F. (2006) Treatment of recurrent erythema nodosum leprosum with infliximab. The New England Journal of Medicine 355, 739.
20. Feller, M., Huwiler, K., Stephan, R., Altpeter, E., Shang, A., Furrer, H., Pfyffer, G.E., Jemmi, T., Baumgartner, A. and Egger, M. (2007) Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. The Lancet Infectious Dis eases 7, 607-613.
21. Feng, C.G., Collazo-Custodio, C.M., Eckhaus, M., Hieny, S., Belkaid, Y., Elkins, K., Jankovic, D., Taylor, G.A. and Sher, A. (2004) Mice deficient in LRG-47 display increased susceptibility to mycobacterial infection associated with the induction of lymphopenia. Journal of Immunology 172, 1163-1168.
22. Ferwerda, G., Girardin, S.E., Kullberg, B.J., Le Bourhis, L., de Jong, D.J., Langenberg, D.M., van Crevel, R., Adema, G.J., Ottenhoff, T.H., van der Meer, J.W. and Netea, M.G. (2005) NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis. PLoS Pathogens 1, 279-285.
23. Fisher, C.J., Jr., Opal, S.M., Dhainaut, J.F., Stephens, S., Zimmerman, J.L., Nightingale, P., Harris, S.J., Schein, R.M., Panacek, E.A., Vincent, J.L. Foulke, G.E., Warren, E.L. Garrard, C., Park, G., Bodmer, M.W., Cohen, J., Van Der Linden, C., Cross, A.S., Sadoff, J.C. and The Cb0006 Sepsis Syndrome Study Group (1993) Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. Critical Care Medicine 21, 318-327.
24. Flores, L.L., Pai, M., Colford, J.M., Jr. and Riley, L.W. (2005) In-house nucleic acid amplification tests for the detection of Mycobacterium tuberculosis in sputum specimens: meta-analysis and meta-regression. BMC Microbiology 5, 55.
25. Gandotra, S., Jang, S., Murray, P.J., Salgame, P. and Ehrt, S. (2007) NOD2-deficient mice control infection with Mycobacterium tuberculosis. Infection and Immunity 75, 5127-5134.
26. Gardam, M.A., Keystone, E.C., Menzies, R., Manners, S., Skamene, E., Long, R. and Vinh, D.C. (2003) Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. The Lancet Infectious Diseases 3, 148-155.
27. Ghadiali, A.H., Strother, M., Naser, S.A., Manning, E.J. and Sreevatsan, S. (2004) Mycobacterium avium subsp. paratuberculosis strains isolated from Crohn's disease patients and animal species exhibit similar polymorphic locus patterns. Journal of Clinical Microbiology 42, 5345-5348.
28. Girardin, S.E., Boneca, I.G., Viala, J., Chamaillard, M., Labigne, A., Thomas, G., Philpott, D.J. and Sansonetti, P.J. (2003) Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. Journal of Biological Chemistry 278, 8869-8872.
29. Greenstein, R.J. (2003) Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis and Johne's disease. The Lancet Infectious Diseases 3, 507-514.
30. Gutierrez, M.G., Master, S.S., Singh, S.B., Taylor, G.A., Colombo, M.I. and Deretic, V. (2004) Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119, 753-766.
31. Inohara, N., Ogura, Y., Fontalba, A., Gutierrez, O., Pons, F., Crespo, J., Fukase, K., Inamura, S., Kusumoto, S., Hashimoto, M., Foster, S.J., Moran, A.P., Fernandez-Luna, J.L. and Nunez, G. (2003) Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. Journal of Biological Chemistry 278, 5509-5512.
32. Jenkins, P.A., Campbell, I.A., Banks, J., Gelder, C.M., Prescott, R.J. and Smith, A.P. (2008) Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy. Thorax 63, 627-634.
33. Jeyanathan, M., Alexander, D.C., Turenne, C.Y., Girard, C. and Behr, M.A. (2006) Evaluation of in situ methods used to detect Mycobacterium avium subsp. paratuberculosis in samples from patients with Crohn's disease. Journal of Clinical Microbiology 44, 2942-2950.
34. Jeyanathan, M., Boutros-Tadros, O., Radhi, J., Semret, M., Bitton, A. and Behr, M.A. (2007) Visualization of Mycobacterium avium in Crohn's tissue by oil-immersion microscopy. Microbes and Infection 9, 1567-1573.
35. Juste, R.A., Elguezabal, N., Garrido, J.M., Pavon, A., Geijo, M.V., Sevilla, I., Cabriada, J.L., Tejada, A., Garcia-Campos, F., Casado, R., Ochotorena, I., Izeta, A. and Greenstein, R.J. (2008) On the prevalence of M. avium subspecies paratuberculosis DNA in the blood of healthy individuals and patients with inflammatory bowel disease. PLoS ONE 3, e2537.
36. Lecuit, M., Dramsi, S., Gottardi, C., Fedor-Chaiken, M., Gumbiner, B. and Cossart, P. (1999) A single amino acid in E-cadherin responsible for host specificity towards the human pathogen Listeria monocytogenes. EMBO Journal 18, 3956-3963.
37. Lowe, A.M., Yansouni, C.P. and Behr, M.A. (2008) Causality and gastrointestinal infections: Koch, Hill and Crohn's. The Lancet Infectious Diseases 8, 720-726.
38. Lowe, A.M., Roy, P.O., Poulin, M., Michel, P., Bitton, A., St-Onge, L. and Brassard, P. (2009) Epidemiology of Crohn's disease in Quebec, Canada. Inflammatory Bowel Disease 15, 429-435.
39. Mackintosh, C.G., de Lisle, G.W., Collins, D.M. and Griffin, J.F. (2004), Mycobacterial diseases of deer. New Zealand Veterinary Journal 52, 163-174.
40. MacMicking, J.D., Taylor, G.A. and McKinney, J.D. (2003) Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science 302, 654-659.
41. Naser, S.A., Ghobrial, G., Romero, C. and Valentine, J.F. (2004) Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. The Lancet 364, 1039-1044.
42. Pandey, A.K., Yang, Y., Jiang, Z., Fortune, S.M., Coulombe, F., Behr, M.A., Fitzgerald, K.A., Sassetti, C.M. and Kelliher, M.A. (2009) NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathogens, Jul 5(7), e1000500.
43. Parrish, N.M., Radcliff, R.P., Brey, B.J., Anderson, J.L., Clark, D.L., Jr., Koziczkowski, J.J., Ko, C.G., Goldberg, N.D., Brinker, D.A., Carlson, R.A., Dick, J.D. and Ellingson, J.L. (2009) Absence of Mycobacterium avium subsp. paratuberculosis in Crohn's patients. Inflammatory Bowel Disease 15, 558-565.
44. Peyrin-Biroulet, L., Neut, C. and Colombel, J.F. (2007) Antimycobacterial therapy in Crohn's disease: game over? Gastroenterology 132, 2594-2598.
45. Pierce, E.S. (2009) Where are all the Mycobacterium avium subspecies paratuberculosis in patients with Crohn's disease? PLoS Pathogens 5, e1000234.
46. Pinedo, P.J., Buergelt, C.D., Donovan, G.A., Melendez, P., Morel, L., Wu, R., Langaee, T.Y. and Rae, D.O. (2009) Association between CARD15/ NOD2 gene polymorphisms and paratuberculosis infection in cattle. Veterinary Microbiology 134, 346-352.
47. Pineton de Chambrun, C.G., Colombel, J.F., Poulain, D. and Darfeuille-Michaud, A. (2008) Pathogenic agents in inflammatory bowel diseases. Current Opinion in Gastroenterology 24, 440-447.
48. Rangel, J.M., Sparling, P.H., Crowe, C., Griffin, P.M. and Swerdlow, D.L. (2005) Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982-2002. Emerging Infectious Diseases 11, 603-609.
49. Raymond, J.B., Mahapatra, S., Crick, D.C. and Pavelka, M.S., Jr. (2005) Identification of the namH gene, encoding the hydroxylase responsible for the N-glycolylation of the mycobacterial peptidoglycan. Journal of Biological Chemistry 280, 326-333.
50. Rioux, J.D., Xavier, R.J., Taylor, K.D., Silverberg, M.S., Goyette, P., Huett, A., Green, T., Kuballa, P., Barmada, M.M., Datta, L.W., Shugart, Y.Y., Griffiths, A.M., Targan, S.R., Ippoliti, A.F., Bernard, E.J., Mei, L., Nicolae, D.L., Regueiro, M., Schumm, L.P., Steinhart, A.H., Rotter, J.I., Duerr, R.H., Cho, J.H., Daly, M.J. and Brant, S.R. (2007) Genome-wide association study identifies new susceptibility loci for Crohn's disease and implicates autophagy in disease pathogenesis. Nature Genetics 39, 596-604.
51. Saitoh, T., Fujita, N., Jang, M.H., Uematsu, S., Yang, B.G., Satoh, T., Omori, H., Noda, T., Yamamoto, N., Komatsu, M., Tanaka, K., Kawai, T., Tsujimura, T., Takeuchi, O., Yoshimori, T. and Akira, S. (2008) Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 456, 264-268.
52. Sandberg, M., Nygard, K., Meldal, H., Valle, P.S., Kruse, H. and Skjerve, E. (2006) Incidence trend and risk factors for campylobacter infections in humans in Norway. BMC Public Health 6, 179.
53. Sartor, R.B. (2005) Does Mycobacterium avium subspecies paratuberculosis cause Crohn's disease? Gut 54, 896-898.
54. Selby, W., Pavli, P., Crotty, B., Florin, T., Radford-Smith, G., Gibson, P., Mitchell, B., Connell, W., Read, R., Merrett, M., Ee, H. and Hetzel, D. (2007) Two-year combination antibiotic therapy with clarithromycin, rifabutin and clofazimine for Crohn's disease. Gastroenterology 132, 2313-2319.
55. Shanahan, F. and O'Mahony, J. (2005) The mycobacteria story in Crohn's disease. American Journal of Gastroenterology 100, 1537-1538.
56. Shih, D.Q., Targan, S.R. and McGovern, D. (2008) Recent advances in IBD pathogenesis: genetics and immunobiology. Current Gastroenterology Reports 10, 568-575.
57. St Amand, A.L., Frank, D.N., De Groote, M.A. and Pace, N.R. (2005) Use of specific rRNA oligonucleotide probes for microscopic detection of Mycobacterium avium complex organisms in tissue. Journal of Clinical Microbiology 43, 1505-1514.
58. Waddell, L.A., Rajic, A., Sargeant, J., Harris, J., Amezcua, R., Downey, L., Read, S. and McEwen, S.A. (2008) The zoonotic potential of Mycobacterium avium ssp. paratuberculosis: a systematic review. Canadian Journal of Public Health 99, 145-155.
59. Winthrop, K.L., Yamashita, S., Beekmann, S.E. and Polgreen, P.M. (2008) Mycobacterial and other serious infections in patients receiving antitumor necrosis factor and other newly approved biologic therapies: case finding through the Emerging Infections Network. Clinical Infectious Diseases 46, 1738-1740.